RAD51 and cancer: While RAD51 mutations do not seem to be responsible for oncogenesis, germline pathogenic variants have been described in CMM syndrome (which is not associated with a cancer predisposition), revealing an unexpected, post-mitotic, and probably cytoplasmic role of RAD51 in brain development.